← FDA Drug Approvals (Drugs@FDA)
ADLARITY
NDA · New Drug Application · Sponsor: CORIUM · Approved 2022-03-11
Drug application
- FDA Application #
NDA212304- Application type
- New Drug Application
- Brand name
- ADLARITY
- Generic name
- Donepezil Hydrochloride
- Active ingredients
- DONEPEZIL HYDROCHLORIDE
- Dosage form
- SYSTEM
- Route
- TRANSDERMAL
- Marketing status
- Discontinued
- Sponsor
- CORIUM
- First approval
- 2022-03-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown